Germany, April 23 -- Germany based GlaxoSmithKline GmbH & Co. KG has secured contract from AOK Baden-Wurttemberg for Pharmaceutical Products - Pharmaceutical discount agreement in accordance with Section 130c (1) SGB V for the active ingredient Molizumab. The value of the contract is worth 22100000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....